Acceleron Pharma EPS of -$5.62


Acceleron Pharma (XLRN): Q3 EPS of -$5.62.

Revenue of $4.27M misses by $1.21M. (PR)

From other sites
Comments (1)
  • JMay2
    , contributor
    Comments (30) | Send Message
     
    Guessing today's sell off was people taking profits from the IPO? Once XLRN starts giving updates on their trials, I expect this stock to boom.
    6 Nov 2013, 02:41 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs